DaVita (NYSE:DVA) Posts Quarterly Earnings Results, Beats Estimates By $0.25 EPS

DaVita (NYSE:DVA) issued its earnings results on Monday. The company reported $2.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.75 by $0.25, Zacks reports. DaVita had a net margin of 7.31% and a return on equity of 115.48%. DaVita updated its FY 2025 guidance to 10.200-11.300 EPS.

DaVita Stock Up 0.4%

DaVita stock traded up $0.53 on Monday, hitting $144.29. 1,275,522 shares of the stock traded hands, compared to its average volume of 820,697. The company has a current ratio of 1.26, a quick ratio of 1.21 and a debt-to-equity ratio of 23.18. The firm has a market cap of $11.09 billion, a P/E ratio of 13.43, a price-to-earnings-growth ratio of 1.07 and a beta of 1.14. The business’s fifty day simple moving average is $145.85 and its 200 day simple moving average is $153.83. DaVita has a 1 year low of $131.44 and a 1 year high of $179.60.

Analyst Ratings Changes

DVA has been the topic of several recent analyst reports. StockNews.com upgraded shares of DaVita from a “hold” rating to a “buy” rating in a report on Friday, April 25th. Barclays raised their target price on shares of DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 18th. Cowen reiterated a “hold” rating on shares of DaVita in a report on Tuesday, February 18th. Finally, Sanford C. Bernstein set a $184.00 price target on shares of DaVita in a report on Friday, February 21st. One investment analyst has rated the stock with a sell rating, four have given a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $166.33.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.